• About Us
  • Company Overview
  • Leadership
  • Investors
  • Strategic Alliances
  • Contacts
  • FibroGen Europe
• Clinical
  • Current Trials
• Research & Development
  • Hypoxia-Inducible Factor
    HIF Biology

     

    HIF-PHI Therapy

     

    Anemia

     

    Cytoprotection/Inflammation
  • Connective Tissue Growth Factor
    CTGF Biology

     

    Anti-CTGF Therapy

     

    Chronic Kidney Disease

     

    Fibrotic Disease

     

    Cancer
  • Recombinant Human Collagen & Gelatin
• News & Events
  • Publications
  • Press Releases
  • Events
  • Email Sign up
• Careers
  • Job Search
  • Notice to Search Firms and Recruiters

Current Trials

For more information about on-going FibroGen clinical trials, please call (866) 266-0012 or email clinical contact.

FG-3019

• FG-3019-029, Phase 1, Diabetic Kidney Disease
  > Treatment complete. Follow up on going
• FG-3019-032, Phase 2, Diabetic Kidney Disease
  > Currently enrolling
• FG-30190-028, Phase 1, Pancreatic Cancer
  > Currently enrolling

FG-4592

• FG-4592-017, Phase 2A, pre-dialysis CKD Anemia
  > Currently enrolling